TABLE 2.
BFPP performance summary for BAL-type and sputum-type specimens
Analytec | PPA |
NPA |
BFPP-pos SOC-NTb |
BFPP-neg SOC-NT | ||||
---|---|---|---|---|---|---|---|---|
Prop.a | % | 95% CId (%) | Prop. | % | 95% CId (%) | |||
Viruses | ||||||||
Rhinovirus/enterovirus | 5/5 | 100 | 56.6–100 | 103/103 | 100 | 96.4–100 | 4 | 88 |
Influenza A virus | 4/5 | 80 | 37.6–99.0 | 104/105 | 99.0 | 94.8–99.9 | 1 | 89 |
Coronavirus | 1/3 | 33.3 | 1.7–88.2 | 106/107 | 99.1 | 94.9–99.9 | 1 | 91 |
Influenza B virus | 3/3 | 100 | 43.9–100 | 107/107 | 100 | 96.5–100 | 1 | 89 |
RSV | 4/4 | 100 | 51.0–100 | 106/106 | 100 | 96.5–100 | 0 | 90 |
Metapneumovirus | 1/1 | 100 | 5.1–100 | 107/107 | 100 | 96.5–100 | 2 | 90 |
Parainfluenza virus | 1/1 | 100 | 5.1–100 | 106/107 | 99.1 | 94.9–99.9 | 0 | 92 |
Adenovirus | 0/1 | 0 | 0–94.9 | 107/107 | 100 | 96.5–100 | 0 | 92 |
Total | 19/23 | 82.6 | 62.9–93.0 | 846/849 | 99.5 | 99.0–99.9 | 9 | 721 |
Bacteria | ||||||||
Staphylococcus aureus | 22/22 | 100 | 85.1–100 | 156/178 | 87.6 | 82.0–91.7 | 0 | 0 |
Haemophilus influenzae | 3/3 | 100 | 43.9–100 | 172/197 | 87.3 | 81.9–91.3 | 0 | 0 |
Pseudomonas aeruginosa | 8/8 | 100 | 67.6–100 | 185/192 | 96.4 | 92.7–98.2 | 0 | 0 |
Enterobacter cloacae complex | 3/4 | 75 | 30.1–98.7 | 189/196 | 96.4 | 92.8–98.3 | 0 | 0 |
Escherichia coli | 6/6 | 100 | 61.0–100 | 190/194 | 97.9 | 94.8–99.2 | 0 | 0 |
Streptococcus pneumoniae | 2/2 | 100 | 17.8–100 | 191/198 | 96.5 | 92.9–98.3 | 0 | 0 |
Klebsiella pneumoniae group | 4/4 | 100 | 51.0–100 | 192/196 | 98.0 | 94.9–99.2 | 0 | 0 |
Streptococcus agalactiae | 2/2 | 100 | 17.8–100 | 193/198 | 97.5 | 94.2–98.9 | 0 | 0 |
Klebsiella aerogenes | 2/2 | 100 | 17.8–100 | 196/198 | 99.0 | 96.4–99.8 | 0 | 0 |
Klebsiella oxytoca | 3/3 | 100 | 43.9–100 | 196/197 | 99.5 | 97.2–99.9 | 0 | 0 |
Moraxella catarrhalis | 1/1 | 100 | 5.1–100 | 196/199 | 98.5 | 95.7–99.6 | 0 | 0 |
Proteus spp. | 0/0 | NAe | NA | 196/200 | 98.0 | 95.0–99.2 | 0 | 0 |
Serratia marcescens | 3/3 | 100 | 43.9–100 | 197/197 | 100 | 98.1–100 | 0 | 0 |
Acinetobacter baumannii–calcoaceticus complex | 0/0 | NA | NA | 199/200 | 99.5 | 97.2–99.9 | 0 | 0 |
Legionella pneumophila | 0/0 | NA | NA | 44/44 | 100 | 92.0–100 | 1 | 156 |
Mycoplasma pneumoniae | 1/1 | 100 | 5.1–100 | 86/86 | 100 | 95.7–100 | 0 | 80 |
Total | 60/61 | 98.4 | 91.3–99.9 | 2778/2870 | 96.8 | 96.1–97.4 | 1 | 236 |
Prop., proportion for positive percent agreement (PPA) or negative percent agreement (NPA), calculated as follows: PPA = concordant positive/all positive results by SOC, and NPA = concordant negative/all negative results by SOC.
BFPP-pos, SOC-NT, analyte detected by BFPP but not tested by standard of care.
SOC testing also detected herpes simplex virus (n = 5), cytomegalovirus (n = 4), Stenotrophomonas maltophilia (n = 4), Acinetobacter spp. (n = 1), Citrobacter freundii complex (n = 1), Klebsiella variicola (n = 1), and Staphylococcus intermedius group (n = 1), which are not included in the BFPP panel. SOC testing detected yeast or mold in an additional 26 samples, including 21 yeasts, 2 Aspergillus spp., 1 Blastomyces dermatitidis/B. gilchristii isolate, 1 Paecilomyces species, and 1 Pneumocystis jirovecii isolate.
CI, confidence agreement for a binomial distribution, calculated by the Wilson/Brown method.
NA, not applicable.